142 related articles for article (PubMed ID: 8838263)
21. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW
Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613
[TBL] [Abstract][Full Text] [Related]
22. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
[TBL] [Abstract][Full Text] [Related]
23. Primary chemoprevention of familial adenomatous polyposis with sulindac: more questions than answers.
Bresalier RS
Gastroenterology; 2002 Jul; 123(1):379-81. PubMed ID: 12105867
[No Abstract] [Full Text] [Related]
24. Oxazole and thiazole analogs of sulindac for cancer prevention.
Mathew B; Hobrath JV; Connelly MC; Guy RK; Reynolds RC
Future Med Chem; 2018 Apr; 10(7):743-753. PubMed ID: 29671617
[TBL] [Abstract][Full Text] [Related]
25. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
Chiu CH; McEntee MF; Whelan J
Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
[TBL] [Abstract][Full Text] [Related]
26. Sulindac-associated ulcerative pouchitis in familial adenomatous polyposis.
Bertoni G; Sassatelli R; Bedogni G; Nigrisoli E
Am J Gastroenterol; 1996 Nov; 91(11):2431-2. PubMed ID: 8931434
[No Abstract] [Full Text] [Related]
27. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of familial adenomatous polyposis.
Lynch PM
Fam Cancer; 2016 Jul; 15(3):467-75. PubMed ID: 27083160
[TBL] [Abstract][Full Text] [Related]
29. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of FAP with sulindac.
Meyskens FL
Curr Oncol Rep; 2002 Nov; 4(6):463. PubMed ID: 12385292
[No Abstract] [Full Text] [Related]
31. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C; Meary N
Bull Cancer; 2004 May; 91 Suppl 2():S85-8. PubMed ID: 15899631
[TBL] [Abstract][Full Text] [Related]
32. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac.
Nugent KP; Spigelman AD; Phillips RK
Dis Colon Rectum; 1996 Jun; 39(6):659-62. PubMed ID: 8646953
[TBL] [Abstract][Full Text] [Related]
33. Reducing the risk of recurrent colon polyps.
Gerner E
Clin Adv Hematol Oncol; 2009 Feb; 7(2):100-2. PubMed ID: 19367249
[No Abstract] [Full Text] [Related]
34. [Aspirin, non-steroidal anti-inflammatory agents and colonic carcinogenesis].
Benamouzig R; Chaussade S; Little J; Munoz N; Rautureau J; Couturier D
Gastroenterol Clin Biol; 1997; 21(3):188-96. PubMed ID: 9161493
[No Abstract] [Full Text] [Related]
35. Discouraging colonic polyps.
Williams CB
Gut; 1997 Mar; 40(3):430. PubMed ID: 9135538
[No Abstract] [Full Text] [Related]
36. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
[TBL] [Abstract][Full Text] [Related]
37. Aspirin and gastrointestinal cancer.
Thun MJ
Adv Exp Med Biol; 1997; 400A():395-402. PubMed ID: 9547582
[TBL] [Abstract][Full Text] [Related]
38. Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen.
Wechter WJ; Murray ED; Kantoci D; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Life Sci; 2000 Jan; 66(8):745-53. PubMed ID: 10680582
[TBL] [Abstract][Full Text] [Related]
39. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
[TBL] [Abstract][Full Text] [Related]
40. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
Schnitzler M; Dwight T; Robinson BG
Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
